EUVIMEDEUVIMED entdecken
Fallbericht

Diagnostic Challenges in Identifying Concurrent Myeloid Sarcoma and High-Grade Prostatic Adenocarcinoma Within the Prostate

Ting Zhao iD, Judith A Ferry iD, James L Netreba, Kristine M Cornejo iD

International Journal of Surgical Pathology · 2026

DOI: 10.1177/10668969251344965 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2026. Verfasst von Ting Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Neoplasms, Multiple Primary, Prostatic Neoplasms, Sarcoma, Myeloid. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid sarcoma is an extramedullary mass lesion composed of myeloid blasts that disrupt tissue architecture. Myeloid sarcoma in the prostate is exceptionally rare, with fewer than 30 patients reported. Among these, 8 have been observed without a prior diagnosis of a hematolymphoid neoplasm. To date, concurrent prostatic myeloid sarcoma and adenocarcinoma have not been documented in the English-language literature. We present the first 2 myeloid sarcomas in the prostate occurring concurrently with high-grade prostatic adenocarcinoma, identified on core needle biopsy and radical prostatectomy in patients without a prior history of myeloid sarcoma or acute myeloid leukemia (AML), and highlight the associated diagnostic challenges. Both were positive for NPM1 by immunohistochemistry, consistent with NPM1 mutation. Neither patient received treatment for myeloid sarcoma/AML due to multiple comorbidities. One patient succumbed to the disease 44 days after diagnosis, while the other passed away from respiratory failure in the context of multiple comorbidities 2 months after being diagnosed with myeloid sarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaNeoplasms, Multiple PrimaryProstatic NeoplasmsSarcoma, MyeloidHumansMaleBiomarkers, TumorBiopsy, Large-Core NeedleFatal OutcomeNuclear ProteinsNucleophosminProstateProstatectomy

Stichwörter der Autor:innen

acute myeloid leukemiabiopsyhigh-grade prostatic adenocarcinomamyeloid sarcomaprostateprostatectomy

Substanzen

Biomarkers, TumorNPM1 protein, humanNuclear ProteinsNucleophosmin

Autor:innen und Institutionen

  • Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Pathology, Mercy Hospital Oklahoma City, Oklahoma City, OK, USA.

ORCID-Profile: Ting Zhao, Judith A Ferry, Kristine M Cornejo

Zitieren

APA

Zhao, T., Ferry, J. A., Netreba, J. L., & Cornejo, K. M. (2026). Diagnostic Challenges in Identifying Concurrent Myeloid Sarcoma and High-Grade Prostatic Adenocarcinoma Within the Prostate. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969251344965

Vancouver

Zhao T, Ferry JA, Netreba JL, Cornejo KM. Diagnostic Challenges in Identifying Concurrent Myeloid Sarcoma and High-Grade Prostatic Adenocarcinoma Within the Prostate. International Journal of Surgical Pathology. 2026. doi:10.1177/10668969251344965

BibTeX
@article{Zhao2026,
  author = {Zhao, Ting and Ferry, Judith A and Netreba, James L and Cornejo, Kristine M},
  title = {Diagnostic Challenges in Identifying Concurrent Myeloid Sarcoma and High-Grade Prostatic Adenocarcinoma Within the Prostate},
  journal = {International Journal of Surgical Pathology},
  year = {2026},
  doi = {10.1177/10668969251344965}
}
Kostenlos starten →